Loading
TuHURA Biosciences, Inc./NV Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Hoffman Robert E., was filed 17 Feb 2022.
TuHURA Biosciences, Inc./NV: what insiders have been doing
This page follows insider dealings at TuHURA Biosciences, Inc./NV as filed with SEC (Form 4), a company from the Health Care sector. Over the twelve months to 22 October 2026, 1 filing were filed, from 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Insider buying of TuHURA Biosciences, Inc./NV has been absent for the past year.
Compared with its exchange (3,171 companies, median 24 filings), a count of 1 filing is below the norm. Over the whole record (from 2016), the tally stands at 25 purchases and no sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported net income of -30.1 m USD.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
154
Thresholds
n/a
Buy Volume
€306,002
25 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- -72.3%Entry US$715.75 · Close at T+365 US$198.45
- -66.3%Entry US$1,155.00 · Close at T+365 US$388.85
- -56.5%Entry US$1,190.00 · Close at T+365 US$518.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$1.78
Analyst consensus
5 analysts1.50/5
US$6.20Target US$8.04(+352%)US$10.00
Income statement
EBITDA-US$29.4M
Net income-US$30.1M0.0% margin
Valuation
PER (forward)-2.9x
P/Book6.2x
Balance sheet & cash
Market capUS$113.4M
Total debtUS$700k
Free Cash Flow-US$27.7M
Debt / Equity50%
Profitability & ownership
ROE-161.4%
ROA-58.4%
% insiders34.6%
% institutions14.3%
Last declaration on 29 May 2026
Declarations154 total
150,000 shares0Common StockSEC:0000897069-26-001285:0
2,323,307 shares0Common StockSEC:0000897069-24-001996:0
59,800 shares0Common Stock, par value $0.001 per shareSEC:0001493152-23-019950:0
363 shares0Common Stock, par value $0.001 per shareSEC:0001493152-23-000860:0
400,145 shares0Common StockSEC:0001493152-22-021170:0
240,087 shares0Common StockSEC:0001493152-22-021171:0
240,087 shares0Common StockSEC:0001493152-22-021172:0
55,000 shares@ US$0.469100.0% of flowCommon StockSEC:0000905718-22-000393:0
Canonical exit: 16 May 2022 (T+90)
28,700 shares@ US$0.677100.0% of flowCommon StockSEC:0000899243-21-047520:0
Canonical exit: 8 Mar 2022 (T+90)
38,109 shares@ US$0.637630.5% of flowCommon StockSEC:0000899243-21-047320:1
Canonical exit: 7 Mar 2022 (T+90)
11,891 shares@ US$0.5902100.0% of flowCommon StockSEC:0000899243-21-047320:0
Canonical exit: 6 Mar 2022 (T+90)
3,000 shares@ US$0.7423100.0% of flowCommon StockSEC:0000899243-21-046043:0
Canonical exit: 20 Feb 2022 (T+90)
8 shares0Common StockSEC:0000905718-21-000630:0
938 sharesCommon StockSEC:0000905718-21-000630:1
3 shares0Common StockSEC:0000905718-21-000629:0
325 sharesCommon StockSEC:0000905718-21-000629:1
6 shares0Common StockSEC:0000905718-21-000631:0
750 sharesCommon StockSEC:0000905718-21-000631:1
22 shares0Common StockSEC:0000905718-21-000501:0
8 shares0Common StockSEC:0000905718-21-000505:0
17 shares0Common StockSEC:0000905718-21-000503:0
22 shares0Common StockSEC:0000899243-21-000042:0
8 shares0Common StockSEC:0000899243-21-000043:0
17 shares0Common StockSEC:0000899243-21-000044:0
17 shares0Common StockSEC:0000905718-20-000997:0
25 of 154 declarations
About TuHURA Biosciences, Inc./NV
TuHURA Biosciences, Inc. is a company focused on developing biopharmaceutical solutions. It is listed on the XNAS market.
